Antigenics ' (nasdaq: AGEN - news - people ) decision to test the drug in chronic myelogenous leukemia (CML), a rare disease developed by more than 4, 000 adults per year, is emblematic of a trendin drug development.
"Our objective is to provide the basic infrastructure, planning and necessary management framework in creating satellite cities that reverses the current trend of unplanned development and urban congestion in most of Africa's growing cities, " says Tim Beighton, of Rendeavour, which is developing several new cities in Africa.